NASDAQ:CVRX CVRx (CVRX) Stock Price, News & Analysis $0.50 -0.03 (-5.99%) Closing price 11/20/2026 04:00 PM EasternExtended Trading$0.50 +0.00 (+0.60%) As of 11/20/2026 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC Filings About CVRx Stock (NASDAQ:CVRX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get CVRx alerts:Sign Up Key Stats Today's Range$0.50▼$0.5750-Day Range$0.50▼$3.0452-Week Range$0.50▼$10.28Volume520,259 shsAverage Volume853,984 shsMarket Capitalization$14.27 millionP/E RatioN/ADividend YieldN/APrice Target$2.70Consensus RatingHold Company Overview CVRx, Inc. is a medical technology company that develops and commercializes implantable neuromodulation devices for cardiovascular conditions. Its technology is designed to influence the autonomic nervous system, which helps regulate functions such as heart rate and blood pressure. The company’s primary product is Barostim, an implantable system that delivers electrical signals to baroreceptors in the carotid artery. In the United States, Barostim is approved to improve symptoms for certain patients with heart failure who remain symptomatic despite medical therapy. CVRx is based in Minneapolis, Minnesota, and serves patients and health care providers in the United States and select international markets.AI Generated. May Contain Errors. Read More CVRx Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks61st Percentile Overall ScoreCVRX MarketRank™: 3.02701567749 of 5 starsCVRx scored higher than 61% of companies evaluated by MarketBeat, and ranked 361st out of 845 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.0 / 5Analyst RatingHold Consensus RatingCVRx has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, 5 hold ratings, and 1 sell rating.Upside PotentialCVRx has a consensus price target of $2.70, representing about 438.9% upside from its current price of $0.50.Amount of Analyst CoverageCVRx has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about CVRx's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for CVRx are expected to grow in the coming year, from ($2.05) to ($1.80) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of CVRx is -0.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of CVRx is -0.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCVRx has a P/B Ratio of 1.02. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted8.19% of the float of CVRx has been sold short.Short Interest Ratio / Days to CoverCVRx has a short interest ratio ("days to cover") of 5.33.Change versus previous monthShort interest in CVRx has recently decreased by 14.89%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCVRx does not currently pay a dividend.Dividend GrowthCVRx does not have a long track record of dividend growth. News and Social Media2.5 / 5News Sentiment0.01 News SentimentCVRx has a news sentiment score of 0.01. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.41 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 25 news articles for CVRx this week, compared to 4 articles on an average week.Search InterestOnly 1 people have searched for CVRX on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.MarketBeat Follows1 people have added CVRx to their MarketBeat watchlist in the last 30 days. Company Ownership1.3 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, CVRx insiders have not sold or bought any company stock.Percentage Held by Insiders16.60% of the stock of CVRx is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions75.27% of the stock of CVRx is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about CVRx's insider trading history. Receive CVRX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CVRx and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CVRX Stock News HeadlinesROSEN, TRUSTED INVESTOR COUNSEL, Encourages CVRx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CVRXNovember 21 at 3:50 PM | markets.businessinsider.comROSEN, TOP RANKED GLOBAL COUNSEL, Encourages CVRx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CVRXNovember 20 at 1:50 PM | markets.businessinsider.comYour Copy is on Hold (Claim it now)James Altucher, who called NVIDIA in 2008 and SpaceX years before a single share traded, has a new report on Elon Musk's next big industry play. He estimates it could create 1.8 million new millionaires in the coming years, and shows how to position in the company at its center for under $60. Inside: the company's name and ticker, plus an FCC filing James believes reveals Elon's plan to take over a $25 trillion industry. He also flags December 8 as a key date.November 21 at 1:00 AM | Paradigm Press (Ad)What's Next for CVRx, Inc. Shareholders After 59.76% Stock Drop? Glancy Prongay Wolke & Rotter LLP Explains Securities Fraud Class Action Lead Plaintiff DeadlineNovember 20 at 1:30 PM | prnewswire.comRobbins LLP Urges CVRX Shareholders Who Lost Money Investing in CVRx, Inc. to Contact the Firm for About Leading the Class ActionNovember 20 at 12:30 PM | prnewswire.comCVRx, Inc. (NASDAQ:CVRX) Stock Rated "Hold" by Wall Street AnalystsNovember 20 at 2:58 AM | americanbankingnews.comROSEN, A LEADING LAW FIRM, Encourages CVRx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CVRXNovember 19 at 6:00 PM | globenewswire.comCVRx ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against CVRx Inc. and Encourages Investors to Contact the FirmNovember 19 at 4:06 PM | globenewswire.comSee More Headlines CVRX Stock Analysis - Frequently Asked Questions How have CVRX shares performed this year? CVRx's stock was trading at $7.10 at the start of the year. Since then, CVRX shares have decreased by 92.9% and is now trading at $0.5010. How were CVRx's earnings last quarter? CVRx, Inc. (NASDAQ:CVRX) issued its earnings results on Thursday, November, 5th. The company reported ($0.52) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.50) by $0.02. The company had revenue of $13.83 million for the quarter, compared to analysts' expectations of $13.93 million. CVRx had a negative net margin of 88.28% and a negative trailing twelve-month return on equity of 208.45%. Read the conference call transcript. When did CVRx IPO? CVRx (CVRX) raised $112 million in an IPO on the week of June 28th 2021. The company issued 7,000,000 shares at a price of $15.00-$17.00 per share. Who are CVRx's major shareholders? CVRx's top institutional investors include Goldman Sachs Group Inc. (1.31%), State Street Corp (1.22%), First Eagle Investment Management LLC (0.83%) and Russell Investments Group Ltd. (0.38%). Insiders that own company stock include & Johnson Johnson, Kirk G Nielsen, Mudit K Jain, Kevin Hykes, Philip B Adamson, Brent Binkowski, Joseph P Slattery and Paul Verrastro. View institutional ownership trends. How do I buy shares of CVRx? Shares of CVRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of CVRx own? Based on aggregate information from My MarketBeat watchlists, some other companies that CVRx investors own include Vanguard U.S. Momentum Factor ETF (VFMO), Aew Uk Reit (AEWU), Abeona Therapeutics (ABEO), RxSight (RXST), AdvanSix (ASIX), The Hanover Insurance Group (THG) and First Trust TCW Unconstrained Plus Bond ETF (UCON). Company Calendar Last Earnings11/05/2026Today11/21/202638th Annual Healthcare Conference12/02/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (3m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 CVRX's financial health is in the Red zone, according to TradeSmith. CVRX has been in this zone for over 3 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:CVRX CIK1235912 Webwww.cvrx.com Phone(763) 416-2850Fax763-416-2841Employees223Year Founded2001Price Target and Rating Average Price Target for CVRx$2.70 High Price Target$4.00 Low Price Target$1.50 Potential Upside/Downside+438.9%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage7 Analysts Profitability EPS (Trailing Twelve Months)($2.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$53.31 million Net Margins-88.28% Pretax Margin-88.29% Return on Equity-208.45% Return on Assets-55.42% Debt Debt-to-Equity Ratio4.24 Current Ratio6.80 Quick Ratio5.71 Sales & Book Value Annual Sales$56.65 million Price / Sales0.25 Cash FlowN/A Price / Cash FlowN/A Book Value$0.49 per share Price / Book1.02Miscellaneous Outstanding Shares28,490,000Free Float23,756,000Market Cap$14.27 million OptionableOptionable Beta0.81 Social Links 10 Best Stocks to Own in Fall 2026AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.Get This Free Report This page (NASDAQ:CVRX) was last updated on 11/20/2026 by MarketBeat.com Staff. From Our PartnersTop Trader Reveals Stunning Black Friday DealOthers paid $500 for the Snapback Indicator. This Black Friday, it's available for just $7. Base Camp Tradi...Base Camp Trading | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | Sponsored432 miles southeast of Washington, DC…Spruce Pine, North Carolina, a town of just over 2,000 people, has supplied a material to every major chip mak...Wall Street Watchdogs | SponsoredBeyond NVDA: The World’s Next #1 Company?This small-cap trades in an overlooked corner of the market, with a market cap more than 600X smaller than Nvi...Banyan Hill Publishing | SponsoredCFA: Bank of America Said THISOn January 24th, 2022, Bank of America told Bloomberg something that should terrify every American with a savi...Decentralized Masters | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CVRx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CVRx With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.